Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
The G7 15-Day System and CGM Innovations at Dexcom, With Jessica Castle, MD
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode of Diabetes Dialogue, host Diana Isaacs, PharmD, is joined by Jessica Castle, MD, vice president of medical affairs at Dexcom, to discuss the company’s recent innovations in continuous glucose monitoring (CGM) and their clinical implications.To open the episode, Castle outlines the launch of the Dexcom G7 15-day system, highlighting its extended wear duration, improved accuracy (MARD ~8%), and strong early adoption among adults. She notes ongoing efforts to optimize sensor longevity…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.